Is Champions Oncology Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: CSBR) stock is to Buy CSBR stock.
Out of 1 analyst, 0 (0%) are recommending CSBR as a Strong Buy, 1 (100%) are recommending CSBR as a Buy, 0 (0%) are recommending CSBR as a Hold, 0 (0%) are recommending CSBR as a Sell, and 0 (0%) are recommending CSBR as a Strong Sell.
What is CSBR's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: CSBR) forecast ROE is N/A, which is considered weak.
What is CSBR's Price Target?
According to 1 Wall Street analyst that have issued a 1 year CSBR price target, the average CSBR price target is $12.00, with the highest CSBR stock price forecast at $12.00 and the lowest CSBR stock price forecast at $12.00.
The Wall Street analyst predicted that Champions Oncology's share price could reach $12.00 by Mar 12, 2026. The average Champions Oncology stock price prediction forecasts a potential upside of 51.52% from the current CSBR share price of $7.92.
What is CSBR's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: CSBR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 103.31%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.